BSE HEALTHCARE INDEX
Why you should invest in health and wellness sector for improved financial health
You’ve heard it time and again — “Health is wealth.” But as one approaches middle age, this adage becomes more than just a cliché. Rising medical costs, especially due to chronic conditions like diabetes, cardiovascular complications, and lifestyle diseases, begin to weigh heavily on personal finances.
Real estate stocks deliver rocket returns this week as BSE Realty eclipses sectoral peers with 10% rally
The real estate sector has emerged as a powerhouse, with the BSE Realty index recording substantial weekly gains. This momentum can be traced back to the Reserve Bank of India's repo rate cut, which has sparked renewed interest in property investments. Leading the charge is Sobha, whose stock has taken off, joined by gains in Financial Services and Metal sectors.
ETMarkets Smart Talk - RBI may cut rates by 50 bps in 2025 as growth needs support, says Dr. Joseph Thomas of Emkay Wealth
Emkay Wealth Management's Dr. Joseph Thomas anticipates a potential RBI rate cut in 2025 amid controlled inflation and growth imperatives. He navigates global volatility from tariff tensions and US bond yield fluctuations, highlighting India's improving earnings and IPO surge. Opportunities exist for long-term investors in SMIDs, infrastructure, PSU equities, consumer discretionary, healthcare, technology, and utilities sectors.
Stock market update: FMCG stocks down as market rises
The 30-share BSE Sensex was up 141.26 points at 80878.77
New launches to drive Sun Pharma’s future growth; PAT may take a hit by tax surge
Sun Pharma anticipates revenue growth for fiscal year 26, building on an 8% increase in fiscal year 25. However, increased spending on marketing specialty products may impact profitability. Net profit declined in the March quarter due to higher taxes. The company plans to launch new drugs like Leqselvi and Unloxcyt.
Stock market update: FMCG stocks up as market falls
The 30-share BSE Sensex closed down 77.26 points at 81373.75
- Go To Page 1
Stock market update: FMCG stocks down as market falls
The 30-share BSE Sensex closed down 182.01 points at 81451.01
Stock market update: FMCG stocks down as market falls
The 30-share BSE Sensex was down 251.16 points at 81381.86
These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 30%, according to analysts
As investors, it is best to ignore what is happening to the Nifty and Sensex… especially on the day of expiry of the monthly contracts in the derivative segment. Index movement is impacted on that day by unwinding and rollover of positions. So, today, don’t look at the indices because they are going to move for reasons that have nothing to do with anything fundamental. Keep an eye on market breadth, and that has been positive in the mid-cap space for some time. Also, focus on the performance of a sector in Q4. Because the street is going to be in stock-specific mode for some time to come.
Stock market update: FMCG stocks down as market falls
The 30-share BSE Sensex closed down 239.31 points at 81312.32
Stock market update: FMCG stocks down as market falls
The 30-share BSE Sensex closed down 239.31 points at 81312.32
Stock market update: FMCG stocks down as market falls
The 30-share BSE Sensex was down 147.76 points at 81403.87
Stock market update: FMCG stocks down as market falls
The 30-share BSE Sensex was down 231.86 points at 81319.77
Stock market update: FMCG stocks down as market falls
The 30-share BSE Sensex was down 808.92 points at 81367.53
Stock market update: FMCG stocks up as market rises
The 30-share BSE Sensex was up 695.71 points at 82416.79
Ahead of Market: 10 things that will decide stock market action on Friday
Indian markets ended sharply lower on Thursday, with Sensex down 645 points and Nifty losing 204 points, as global concerns and US tax bill discussions triggered profit booking. Analysts flagged weak near-term technical trends and expect further correction if key supports break.
Large & midcaps give a photo finish on 1-year returns, smallcaps trail by margin
Large and midcap indices delivered similar 1-year returns, with Nifty Midcap 100 slightly outperforming Nifty 100 though the the 50-stock Nifty has a superior 12-month return of 10%. FIIs favoured largecaps amid expensive mid- and smallcap valuations, driving market preference toward stability. Smallcaps underperformed due to valuation concerns. Divi's Labs, BSE and PG Electroplast have been toppers in respective categories.
Ahead of Market: 10 things that will decide stock market action on Thursday
Markets ended higher on Wednesday, breaking a three-day losing streak as financials, auto, and IT stocks rallied. ICICI Bank and Axis Bank led the Sensex gains, closing above 81,500.
Stock market update: FMCG stocks up as market rises
The 30-share BSE Sensex closed up 410.19 points at 81596.63
Stock market update: FMCG stocks up as market rises
The 30-share BSE Sensex closed up 410.19 points at 81596.63
Stock market update: FMCG stocks up as market rises
The 30-share BSE Sensex was up 593.84 points at 81780.28
Sensex rises! These stocks are up over 10% on BSE
In the Nifty 50 index, 48 stocks were trading in the green, while 2 stocks were trading in the red.
Sensex rises! These stocks are up over 10% on BSE
In the Nifty 50 index, 48 stocks were trading in the green, while 2 stocks were trading in the red.
Stock market update: FMCG stocks down as market falls
The 30-share BSE Sensex was down 225.87 points at 81833.55
Smallcaps vs Largecaps: As markets recover, which is the better investment bet currently?
Smallcap stocks have recently outperformed largecaps, sparking debate among investors. While smallcaps offer high growth potential but come with increased risk, largecaps provide stability with potentially lower returns. Experts suggest a diversified approach, considering individual risk tolerance and investment goals, as large caps are better positioned for investment in the current cycle.
DRL gears up for biosimilar push, consumer health growth post record FY25
Dr Reddy’s stock rose 5.5% in six sessions post-Q4 results, outperforming the BSE Healthcare index. Strong revenue growth, biosimilar launches, and semaglutide portfolio support long-term prospects despite Revlimid taper and reduced target prices by analysts.
Mutual funds bet big on healthcare stocks after Trump’s tariff pause. Is the danger really over?
Following Trump's tariff pause in April 2025, the Nifty Healthcare index rebounded strongly, rising 7%. Mutual funds increased holdings in several healthcare stocks, with Syngene International seeing the highest buying. While some stocks like Zydus Lifesciences faced sell-offs, the sector's overall performance remained robust, outperforming the Nifty.
Stock market update: FMCG stocks up as market rises
The 30-share BSE Sensex closed up 1200.18 points at 82530.74
Load More
